Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PF8380 是有效的autotaxin 抑制剂,在体外酶实验和人类全血细胞实验中的IC50分别为 2.8 nM 和 101 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 218 | 现货 | ||
5 mg | ¥ 413 | 现货 | ||
10 mg | ¥ 663 | 现货 | ||
25 mg | ¥ 1,390 | 现货 | ||
50 mg | ¥ 2,320 | 现货 | ||
100 mg | ¥ 3,730 | 现货 | ||
200 mg | ¥ 5,330 | 现货 | ||
500 mg | ¥ 7,150 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 455 | 现货 |
产品描述 | PF-8380 is an effective and orally available autotaxin inhibitor (IC50: 2.8 nM, in isolated enzyme assay; 101 nM, in the human whole blood). It modulates lysophosphatidic acid (LPA) levels in vivo/vitro by directly inhibiting autotaxin; reduces LPA levels both in plasma and at the site of inflammation. |
靶点活性 | ATX:2.8 nM |
体外活性 | 在放射辐射前,PF-8380预处理可抑制辐射诱导的肿瘤血管内皮细胞血管生成、并延迟神体内经胶质瘤肿瘤生长与发展[2]. 在大鼠气囊炎模型中,PF8380(30 mg/kg,p.o.)可减少炎性痛觉过敏,3 h内可使血浆和炎症组织的LPA水平降低超过95%. |
体内活性 | PF-8380与FS-3D底物抑制大鼠自毒素(IC50:1.16 nM)。在人体全血中,PF-8380处理2 h可抑制自毒素(IC50:101 nM)[1]。PF-8380可抑制GBM细胞的自毒素,随后使其入侵及迁移减少、并使辐射敏化增强。 |
激酶实验 | FS-3 substrate is solubilized in assay buffer at 500 μM and frozen at -20°C in single-use aliquots for up to 4 weeks. Recombinant autotaxin is diluted in Tris-buffered saline (140 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 50 mM Tris, pH 8.0) and incubated with compound in DMSO or DMSO alone (final 1% DMSO) for 15 min at 37°C, and the reaction is started with the addition of FS-3 at a final concentration of 1 μM. The reaction is allowed to proceed at 37°C for 30 min and monitored at 520 nm until the uninhibited control compared with a no-enzyme control gave a Z′≥0.5. IC50s are determined in triplicate by using a four-parameter fit[1]. |
细胞实验 | GL261 or U87-MG cells are plated in triplicate onto 6 cm plates and allowed to grow to 70% confluence. The semi-confluent cell layer is scratched with a sterile 200 μL pipette tip to create a scratch devoid of cells and plates are washed once with PBS to remove non-adherent cells and debris. For radiosensitization drug studies, cells are treated with 1 μM PF-8380 or DMSO for 45 min prior to irradiation with 4 Gy, and then incubated at 37°C in 5% CO2. Control plates are monitored for cell migration (20–24 h). Cells are fixed with 70% ethanol and stained with 1% methylene blue. To quantify migration, cells in three randomly selected high power fields (HPFs) in the scratched area are counted and normalized for surrounding cell density.(Only for Reference) |
分子量 | 478.33 |
分子式 | C22H21Cl2N3O5 |
CAS No. | 1144035-53-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 47.8 mg/mL (100 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 2.0906 mL | 10.453 mL | 20.9061 mL | 52.2652 mL |
5 mM | 0.4181 mL | 2.0906 mL | 4.1812 mL | 10.453 mL | |
10 mM | 0.2091 mL | 1.0453 mL | 2.0906 mL | 5.2265 mL | |
20 mM | 0.1045 mL | 0.5227 mL | 1.0453 mL | 2.6133 mL | |
50 mM | 0.0418 mL | 0.2091 mL | 0.4181 mL | 1.0453 mL | |
100 mM | 0.0209 mL | 0.1045 mL | 0.2091 mL | 0.5227 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
PF-8380 1144035-53-9 Metabolism PDE inhibit Phosphodiesterase (PDE) PF 8380 PF8380 Inhibitor inhibitor